Anaphylaxis News and Research

RSS
Anaphylaxis is an acute multi-system severe type I hypersensitivity reaction. Due in part to the variety of definitions, between 1% and 15% of the population of the United States can be considered "at risk" for having an anaphylactic reaction if they are exposed to one or more allergens. Of those people who actually experience anaphylaxis, up to 1% may die as a result.
Food allergies are on the rise but effective treatment in the pipeline

Food allergies are on the rise but effective treatment in the pipeline

Xolair (Omalizumab) shows promise in treating allergic asthma inadequately controlled by inhaled corticosteroid

Xolair (Omalizumab) shows promise in treating allergic asthma inadequately controlled by inhaled corticosteroid

Cervical cancer vaccine Gardasil can cause an allergic reaction

Cervical cancer vaccine Gardasil can cause an allergic reaction

Most vaccine-allergic children can still be safely vaccinated

Most vaccine-allergic children can still be safely vaccinated

Adverse events from antibiotics cause 142,000 emergency department visits per year in U.S.

Adverse events from antibiotics cause 142,000 emergency department visits per year in U.S.

Students with food allergies often not prepared

Students with food allergies often not prepared

NIAID announces grants to stimulate food allergy research

NIAID announces grants to stimulate food allergy research

Link between soy milk and peanut allergies dispelled

Link between soy milk and peanut allergies dispelled

World Allergy report calls for urgent worldwide collaboration to tackle global increase in allergies

World Allergy report calls for urgent worldwide collaboration to tackle global increase in allergies

Allergy expert says expect cure for peanut allergy in five years

Allergy expert says expect cure for peanut allergy in five years

Tredaptive and Janumet recommended for approval in European Union

Tredaptive and Janumet recommended for approval in European Union

Childhood allergies interfere with sleep

Childhood allergies interfere with sleep

Researchers find cause of severe allergic reaction to cetuximab

Researchers find cause of severe allergic reaction to cetuximab

XYNTHA approved for teatment of hemophilia A by FDA

XYNTHA approved for teatment of hemophilia A by FDA

FDA approves XYZAL (levocetirizine dihydrochloride) for allergies and chronic idiopathic urticaria

FDA approves XYZAL (levocetirizine dihydrochloride) for allergies and chronic idiopathic urticaria

Lack of training in prescribing medicines for children

Lack of training in prescribing medicines for children

FDA approves Tysabri to treat Crohn's disease

FDA approves Tysabri to treat Crohn's disease

Living with nut allergies

Living with nut allergies

Strange behaviours linked to popular sleeping pill Zolpidem

Strange behaviours linked to popular sleeping pill Zolpidem

Protein in mice known as RGS13 suppresses allergic reactions

Protein in mice known as RGS13 suppresses allergic reactions